Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine

The combination of cisplatin and gemcitabine is still one of the most frequently used first-line chemotherapy scheme in patients with advanced non-small cell lung cancer (NSCLC), in which tyrosine kinase inhibitors (TKIs) cannot be administered. Unfortunately, more than half of the patients have no...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathol Oncol Res
Hauptverfasser: Mlak, Radosław, Krawczyk, Paweł, Homa-Mlak, Iwona, Powrózek, Tomasz, Ciesielka, Marzanna, Kozioł, Piotr, Milanowski, Janusz, Małecka-Massalska, Teresa
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Netherlands 2018
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6614130/
https://ncbi.nlm.nih.gov/pubmed/30066234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-018-0459-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge